BrainsWay Ltd. (BWAY) Financials
BWAY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 122.0 million | 42.8 million |
| March 31, 2026 | 117.0 million | 41.2 million |
| Dec. 31, 2025 | 112.9 million | 39.7 million |
| Sept. 30, 2025 | 113.1 million | 43.0 million |
BWAY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 5.5 million | ? |
| March 31, 2026 | 402000 | 342000 |
| Dec. 31, 2025 | -759000 | 280000 |
| Sept. 30, 2025 | 586000 | 364000 |
BWAY Net Income
No data available :(
BWAY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 62.4 million | - | 5.9 million |
| March 31, 2026 | 59.8 million | - | 6.7 million |
| Dec. 31, 2025 | 69.1 million | - | 6.8 million |
| Sept. 30, 2025 | 70.5 million | - | 6.8 million |
BWAY Shares Outstanding
BWAY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 897549 | 3.3 million | 7.3 million | - |
| March 31, 2026 | 769000 | 2.9 million | 6.8 million | 4.9 million |
| Dec. 31, 2025 | 1.3 million | 2.5 million | 6.7 million | 5.1 million |
| Sept. 30, 2025 | 800000 | 2.4 million | 6.5 million | 4.7 million |
BWAY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 17.4 million | 4.4 million |
| March 31, 2026 | 15.5 million | 3.9 million |
| Dec. 31, 2025 | 14.5 million | 3.4 million |
| Sept. 30, 2025 | 13.5 million | 3.4 million |
BWAY
Price: $11.77
52 week price:
Earnings Per Share: 0.23 USD
P/E Ratio: 63.74
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: Israel
Volume: 22800
Market Capitalization: 490.3 million